Compositions and methods for treating mast-cell mediated conditions
    3.
    发明授权
    Compositions and methods for treating mast-cell mediated conditions 失效
    用于治疗肥大细胞介导的病症的组合物和方法

    公开(公告)号:US06211228B1

    公开(公告)日:2001-04-03

    申请号:US09280227

    申请日:1999-03-29

    IPC分类号: A61K71335

    摘要: Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.

    摘要翻译: 描述了有效预防和治疗肥大细胞介导的炎症性疾病的新型化合物,组合物和方法。 化合物,组合物和方法对于预防和治疗与呼吸道相关的炎性疾病如哮喘和过敏性鼻炎以及其它类型的免疫性炎症性疾病如类风湿性关节炎,结膜炎和炎性肠病是有效的, 各种皮肤病学条件,以及某些病毒状况。 这些化合物包括肥大细胞蛋白酶类胰蛋白酶的有效和选择性抑制剂。 用于治疗这些病症的组合物包括口服,吸入,局部和肠胃外制剂以及包含这些制剂的装置。